المؤلفون: Oosting, Linette T., Franke, Katka, Martin, Michael, Kloosterman, Wigard P., Jamieson, Jennifer A., Glenn, Laura A., de Jager, Miranda W., van Zanten, Jacoba, Allersma, Derk P., Gareb, Bahez

المصدر: Oosting , L T , Franke , K , Martin , M , Kloosterman , W P , Jamieson , J A , Glenn , L A , de Jager , M W , van Zanten , J , Allersma , D P & Gareb , B 2022 , ' Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer ' , Pharmaceutics , vol. 14 , no. 7 , 1515 . https://doi.org/10.3390/pharmaceutics14071515Test

مصطلحات موضوعية: formulation, vaccine, neoantigen, peptide, Montanide ISA 51 VG, framome, immunotherapy, non-small cell lung cancer, personalized, SOMATIC MUTATIONS, MELANOMA

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/fb374d3c-37d2-4e25-9b9a-6989207e4944Test

الإتاحة: https://doi.org/10.3390/pharmaceutics14071515Test
https://hdl.handle.net/11370/fb374d3c-37d2-4e25-9b9a-6989207e4944Test
https://research.rug.nl/en/publications/fb374d3c-37d2-4e25-9b9a-6989207e4944Test
https://pure.rug.nl/ws/files/234450502/Development_of_a_Personalized_Tumor_Neoantigen_Based_Vaccine_Formulation_FRAME_001_for_Use_in_a_Phase_II_Trial_for_the_Treatment_of_Advanced_Non_Small_Cell_Lung_Cancer.pdfTest

المؤلفون: Linette T. Oosting, Katka Franke, Michael V. Martin, Wigard P. Kloosterman, Jennifer A. Jamieson, Laura A. Glenn, Miranda W. de Jager, Jacoba van Zanten, Derk P. Allersma, Bahez Gareb

المصدر: Pharmaceutics; Volume 14; Issue 7; Pages: 1515

مصطلحات موضوعية: formulation, vaccine, neoantigen, peptide, Montanide ISA 51 VG, framome, immunotherapy, non-small cell lung cancer, personalized

وصف الملف: application/pdf

العلاقة: Physical Pharmacy and Formulation; https://dx.doi.org/10.3390/pharmaceutics14071515Test

الإتاحة: https://doi.org/10.3390/pharmaceutics14071515Test